Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析

◆英語タイトル:Endocyte Inc (ECYT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14975
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte’s proprietary small molecule drug conjugate (SMDC) technology is used to create novel SMDCs and companion imaging agents for personalized targeted therapies. The company develops therapeutic immunotherapy approach that involves potent immune cells, called chimeric antigen receptor T-cell (CAR T-cell) to fight cancer. It has operations in Indianapolis and West Lafayette. Endocyte is headquartered in West Lafayette, Indiana, the US.

Endocyte Inc Key Recent Developments

Nov 07,2018: Endocyte provides third quarter 2018 financial results and operational update
Oct 19,2018: Novartis to acquire US cancer drug developer Endocyte for $2.1bn
Oct 03,2018: Endocyte becomes first Purdue startup to reach $1.5B in value
Sep 10,2018: Endocyte Announces FDA Acceptance of Radiographic Progression Free Survival (rPFS) as an Alternative Primary Endpoint of the VISION Trial in Addition to Overall Survival (OS)[Newswire : Healthcare - GNW RSS]
Aug 28,2018: Endocyte Announces Presentations at the CAR-TCR Summit 2018

This comprehensive SWOT profile of Endocyte Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Endocyte Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Endocyte Inc – Key Information
Endocyte Inc – Overview
Endocyte Inc – Key Employees
Endocyte Inc – Key Employee Biographies
Endocyte Inc – Key Operational Heads
Endocyte Inc – Major Products and Services
Endocyte Inc – History
Endocyte Inc – Company Statement
Endocyte Inc – Locations And Subsidiaries
Endocyte Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Endocyte Inc – Business Description
Endocyte Inc – Corporate Strategy
Endocyte Inc – SWOT Analysis
SWOT Analysis – Overview
Endocyte Inc – Strengths
Endocyte Inc – Weaknesses
Endocyte Inc – Opportunities
Endocyte Inc – Threats
Endocyte Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Endocyte Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Endocyte Inc, Key Information
Endocyte Inc, Key Ratios
Endocyte Inc, Share Data
Endocyte Inc, Major Products and Services
Endocyte Inc, History
Endocyte Inc, Key Employees
Endocyte Inc, Key Employee Biographies
Endocyte Inc, Key Operational Heads
Endocyte Inc, Other Locations
Endocyte Inc, Subsidiaries
Endocyte Inc, Key Manufacturing facilities
Endocyte Inc, Key Competitors
Endocyte Inc, SWOT Analysis
Endocyte Inc, Ratios based on current share price
Endocyte Inc, Annual Ratios
Endocyte Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Endocyte Inc, Performance Chart
Endocyte Inc, Ratio Charts

★海外企業調査レポート[Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meera Industries Ltd (540519):企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Berjaya Corporation Berhad:企業の戦略・SWOT・財務情報
    Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • S.C. Termoelectrica SA:企業の戦略的SWOT分析
    S.C. Termoelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Centre for Commercialization of Regenerative Medicine-製薬・医療分野:企業M&A・提携分析
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is an healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, bio materials and devices manufacturing. The center’s cell reprogramming and engineering offers various capabilities such as esta …
  • Lattice Semiconductor Corp (LSCC):企業の財務・戦略的SWOT分析
    Lattice Semiconductor Corp (LSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Dong Wha Pharma Co Ltd (000020):企業の財務・戦略的SWOT分析
    Summary Dong Wha Pharma Co Ltd (Dongwha Pharm) is a pharmaceutical company that offers generic products. The company offers ethical drugs, over-the-counter products, cosmetics, health foods, medical devices, and food and drinks. Its products comprise clzapine tablets, valaboom, aripico tablets, intr …
  • Solid Biosciences Inc (SLDB):製薬・医療:M&Aディール及び事業提携情報
    Summary Solid Biosciences Inc (Solid Biosciences) is a life science company focused on developing therapies for duchenne muscular dystrophy (DMD). Its pipeline product candidates include SGT-001, a microdystrophin gene therapy administered through adeno-associated virus (AAV) stabilizes dystrophin g …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tivo Corporation:戦略・SWOT・企業財務分析
    Tivo Corporation - Strategy, SWOT and Corporate Finance Report Summary Tivo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Catabasis Pharmaceuticals Inc (CATB):製薬・医療:M&Aディール及び事業提携情報
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Idaho Power Co:発電所・企業SWOT分析
    Idaho Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Credit Du Nord Sa:企業の戦略・SWOT・財務分析
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hunt’s Foodservice Ltd:企業の戦略・SWOT・財務情報
    Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report Summary Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nishat Mills Ltd:企業の戦略・SWOT・財務分析
    Nishat Mills Ltd - Strategy, SWOT and Corporate Finance Report Summary Nishat Mills Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EMCORE Corporation (EMKR):企業の財務・戦略的SWOT分析
    EMCORE Corporation (EMKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tufts Medical Center-医療機器分野:企業M&A・提携分析
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Venator Materials PLC (VNTR):企業の財務・戦略的SWOT分析
    Venator Materials PLC (VNTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Saudi Industrial Investment Group (2250):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Investment Group (SIIG) is a petrochemical company that invests, improves and develops petrochemical industry. The company produces cyclohexane, benzene, ethylene, polyethylene, hexane, polypropylene and polystyrene. It also provides propylene, styrene, motor gasoline blend, …
  • Biognosys AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Biognosys AG (Biognosys) is a proteomics company which offers tools and services for highly multiplexed protein quantification. Its products portfolio includes calibration kits for reproducible mass spectrometry proteomics, and prediction of peptide retention; software support for multiple a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆